BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 23144293)

  • 21. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy.
    Badawy AA
    Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37486805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas.
    Bostian AC; Eoff RL
    Chem Res Toxicol; 2016 Sep; 29(9):1369-80. PubMed ID: 27482758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the Kynurenine Pathway in CD8
    Braidy N; Rossez H; Lim CK; Jugder BE; Brew BJ; Guillemin GJ
    Neurotox Res; 2016 Nov; 30(4):620-632. PubMed ID: 27510585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Oxenkrug GF
    Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
    Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
    Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
    Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the role of the kynurenine pathway in human breast cancer immunobiology.
    Heng B; Lim CK; Lovejoy DB; Bessede A; Gluch L; Guillemin GJ
    Oncotarget; 2016 Feb; 7(6):6506-20. PubMed ID: 26646699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.
    Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan S; Grant R; Brew BJ; Guillemin GJ
    Neurotox Res; 2010 Aug; 18(2):132-42. PubMed ID: 19921535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
    Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
    Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
    Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
    Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
    Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
    Front Immunol; 2020; 11():31. PubMed ID: 32153556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Kynurenine Pathway Metabolites on Intracellular NAD Synthesis and Cell Death in Human Primary Astrocytes and Neurons.
    Braidy N; Grant R; Brew BJ; Adams S; Jayasena T; Guillemin GJ
    Int J Tryptophan Res; 2009; 2():61-9. PubMed ID: 22084582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
    Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
    Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
    J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
    Breda C; Sathyasaikumar KV; Sograte Idrissi S; Notarangelo FM; Estranero JG; Moore GG; Green EW; Kyriacou CP; Schwarcz R; Giorgini F
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5435-40. PubMed ID: 27114543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in clinical trials targeting the kynurenine pathway.
    Pires AS; Sundaram G; Heng B; Krishnamurthy S; Brew BJ; Guillemin GJ
    Pharmacol Ther; 2022 Aug; 236():108055. PubMed ID: 34929198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.